Suppr超能文献

肺量测定限制性患者的支气管反应性。

Bronchial responsiveness in patients with restrictive spirometry.

机构信息

Division of Pulmonary/Critical Care Medicine, the Oklahoma City VA Medical Center and the University of Oklahoma Health Sciences Center, 920 Stanton L. Young Boulevard, WP 1310, Oklahoma City, OK 73104-5020, USA.

出版信息

Biomed Res Int. 2013;2013:498205. doi: 10.1155/2013/498205. Epub 2013 Aug 18.

Abstract

BACKGROUND

Improvement in PFT after bronchodilators is characteristic of obstructive airway diseases such as COPD. However, improvement in patients with restrictive pattern is occasionally seen. We aim to determine the clinical significance of a bronchodilator responsive restrictive defect.

METHODS

Patients with restrictive spirometry and a bronchodilator study were identified at the University of Oklahoma and Oklahoma City VAMC between September 2003 and December 2009. Restriction was defined as a decreased FVC and FEV1, with normal FEV1/FVC. Responsiveness to bronchodilators was defined as an improvement in FEV1 and/or FVC of at least 12% and 200 mL. Patients with lung volume measurements had their clinical and radiographic records reviewed.

RESULTS

Twenty-one patients were included in the study. Most were current or ex-smokers, with most being on bronchodilators. The average FVC and FEV1 were 65 ± 11% and 62 ± 10% of the predicted, respectively. Most patients (66%) had a normal TLC, averaging 90 ± 16% of the predicted. RV, RV/TLC, and the TLC-VA values strongly suggested an obstructive defect.

CONCLUSIONS

Reversible restrictive pattern on spirometry appears to be a variant of obstructive lung disease in which early airway closure results in air trapping and low FVC. In symptomatic patients, a therapeutic trial of bronchodilators may be beneficial.

摘要

背景

支气管扩张剂后 PFT 的改善是 COPD 等阻塞性气道疾病的特征。然而,限制性模式的患者偶尔也会出现改善。我们旨在确定支气管扩张剂反应性限制缺陷的临床意义。

方法

2003 年 9 月至 2009 年 12 月,在俄克拉荷马大学和俄克拉荷马城退伍军人事务医疗中心确定了具有限制性肺量计和支气管扩张剂研究的患者。限制定义为 FVC 和 FEV1 降低,FEV1/FVC 正常。支气管扩张剂的反应性定义为 FEV1 和/或 FVC 至少改善 12%和 200 mL。对进行了肺量测量的患者,回顾了其临床和影像学记录。

结果

研究纳入了 21 名患者。大多数是当前或曾经吸烟者,大多数正在使用支气管扩张剂。平均 FVC 和 FEV1 分别为预测值的 65 ± 11%和 62 ± 10%。大多数患者(66%)TLC 正常,平均为预测值的 90 ± 16%。RV、RV/TLC 和 TLC-VA 值强烈提示存在阻塞性缺陷。

结论

肺量计上可逆的限制性模式似乎是一种阻塞性肺疾病的变体,其中早期气道关闭导致空气滞留和 FVC 降低。在有症状的患者中,支气管扩张剂的治疗试验可能是有益的。

相似文献

1

引用本文的文献

本文引用的文献

3
Restrictive impairment in patients with asthma.哮喘患者的限制性损害。
Respir Med. 2007 Feb;101(2):272-6. doi: 10.1016/j.rmed.2006.05.008. Epub 2006 Jun 22.
4
Interpretative strategies for lung function tests.肺功能测试的解读策略。
Eur Respir J. 2005 Nov;26(5):948-68. doi: 10.1183/09031936.05.00035205.
5
Standardisation of spirometry.肺活量测定法的标准化
Eur Respir J. 2005 Aug;26(2):319-38. doi: 10.1183/09031936.05.00034805.
8
Small airways obstruction syndrome.
Chest. 1999 Jul;116(1):231-3. doi: 10.1378/chest.116.1.231.
10

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验